期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

缬沙坦对糖尿病大鼠肾脏nephrin表达的影响 被引量：2

Effect of valsartan to expression of nephrin in the kidney of diabetic rats
原文传递
导出
摘要 目的观察缬沙坦干预治疗后糖尿病大鼠肾脏nephrin表达的变化,探讨缬沙坦保护肾脏的部分机制。方法以链脲佐菌素建立糖尿病大鼠模型,缬沙坦干预治疗10周,观察大鼠糖代谢、肾功能及肾小球中nephrin表达的变化。结果模型组大鼠24 h尿蛋白含量显著增加,肾小球nephrin表达显著减少,而缬沙坦干预治疗组上述指标改善(P<0.05),且蛋白尿的程度与nephrin表达呈负相关(P<0.05)。结论缬沙坦可减少糖尿病肾病大鼠尿蛋白的排出,其机制可能与其减少肾小球nephrin表达有关。 Objective To observe the protective effect of valsartan（an angiotensin receptor blocker） on the kidney function and nephrin expression in diabetic rats,and to study the possible mechanisms of valsartan protecting the kidney function of DN. Methods We induced the diabetic rat model by a single intraperitoneal injection of streptozocin（STZ）. After 10 weeks treatment with valsartan, to assess the change of glucose metabolism, kidney function and nephrin. Results The test showed that the volume of 24 hour urine albumin in model group significantly increased and the expression of nephrin in kidney significantly decreased while it significantly ameliorated in valsartan group. Conclusion Valsartan decreased the urine albumin excretory rate in rats with diabetes meUitus nephrothy,which mechanism may be at least partly correlated with lessening the reduction of expression of nephrin in kidney.
作者 黄淑妍 陈澍 刘雪芳 张一萍 钟艺
机构地区 广州医学院第二附属医院老年病科 广州医学院第二附属医院内分泌科 广州医学院第二附属医院药学部
出处 《中国基层医药》 CAS 2006年第12期1967-1969,共3页 Chinese Journal of Primary Medicine and Pharmacy
基金 广东省广州市中医药中西医结合科研课题(2004A059)
关键词 糖尿病肾病 蛋白 NEPHRIN 血管紧张素Ⅱ受体拮抗剂 缬沙坦 Diabetic nephropathy Protein, nephrin Angiotensin receptor blocker Valsartan
分类号 R587.1 [医药卫生—内分泌]
  • 相关文献

参考文献8

  • 1Tryggvason K.Unraveling the mechanisms of glomerular ultrafiltration:nephrin,a key compinent of the slit diaphragm.J Am Soc Nephrol,1999,10(11):2440-2445.
  • 2Brenner BM,Cooper ME,Zeeuw D,et al.The losartan renal protection study:rationale,study design and baseline characteristics of RENAAL(Reduction of Endpoints in NIDDM with the Angiotensin Ⅱ Antagonist Losartan).J Renin Angiotensin Aldosterone Syst,2000,1(4):328-335.
  • 3Parving HH,Lehnent H,Brochner-Mortensen J,et al.The effect of irbesartan on the development of diabetic nephropathy in the patients with type 2 diabetes.N Engl J Med,2001,345(12):870-878.
  • 4Viberti G,Wheeldon MD,MARVAL Study Investigators.Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus:a blood pressure-independent effect.Circulation,2002,106(6):672-678.
  • 5Aaltonen P,Luimula P.Changes in the expression of nephrin gene and protein in a diabetic nephropathy.Lab Ivest,2001,81(9):1185-1190.
  • 6Benigni A,Gagliardini E,Tomasone S,et al.Selective impairment of gene expression and assembly of nephrin in human diabetic nephropathy.Kidney Int,2004,65 (6):2193-2200.
  • 7Schwarz K,Simons M,Rciser J,et al.Podocin,a raft-associated component of the glomerular slit diaphragm,interacts with CD2AP and nephrin.J Clin Invest,2001,108 (11):1621-1629.
  • 8李晶,于德民.肾素—血管紧张素系统阻断剂与胰岛功能保护[J].国际内分泌代谢杂志,2006,26(3):157-159. 被引量：4

二级参考文献24

  • 1Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension, 2001,37:1053-1059.
  • 2McFarlane SI, Kumar A, Sowers JR. Mechanisms by which angiotensinconverting enzyme inhibitors prevent diabetes and eardiovascular disease. Am J Candiol, 2003,91 : H30-H37.
  • 3Yamagishi S, Takenaka K, inoue H. Role of insulin-sensitizing property of telmisartan, a commercially available angiotensin Ⅱ type Ⅰ recoptor blocker in preventing the development of atrial fibrillation. Med Hypotheses, 2006,66:118-120.
  • 4Gillespie EL, White CM, Kardas M, et al. The impact of ACE inhibitors angiotensin Ⅱ type Ⅰ receptor blockers on the development of new-onset type 2 diabetes. Diabetes Care, 2005,28 : 2261-2266.
  • 5Ko SH, Kwon HS, Kim SR, et al. Ramipril treatment suppresses islet fibrosis in Otsuka Long-Evans Tokushima fatty rats. Biochem Biophys Res Commun,2004,316:114-122.
  • 6Blendea MC, Jacobs D, Stump CS, et al. Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin Ⅱ overexpression. Am J Physiol Endocrinol Metab, 2005, 288: E353-E359.
  • 7Oliveira HR, Verlengia R, Carvalho CR, et al. Pancreatic beta-cells express phagocyte-like NAD(P)H oxidase. Diabetes,2003,52:1457-1463.
  • 8Cal H, Li Z, Dikalov S, et al. NAD(P)H oxidase-derived hydrogen peroxide mediates endothelial nitric oxide production in response to angiotensin Ⅱ. J Biol Chem, 2002,277 : 48311-48317.
  • 9Henriksen KI, Jacob S. Angiotensin converting enzyme inhibitors and modulation of skeletal muscle insulin resistance.Diabetes Obes Metab,2003,5:214-222.
  • 10Miyata T. Alterations of non-enzymatic biochemistry in uremia, diabetes,and atherosclerosis ('carbonyl stress'). Bull Mem Acad R Med Belg,2002,157:189-198.

共引文献3

同被引文献19

  • 1何冰,韩萍,吕先科.2型糖尿病患者急性时相蛋白与糖尿病肾病的关系[J].中华内分泌代谢杂志,2003,19(4):260-262. 被引量：170
  • 2Sasso FC, Carbonara O, Persico M, et al. Irbesartan reduces the albumin excretion rate in microalbuminuric type :2 diabetic patients independently of hypertension. Diabetes Care, 2002,25 ( 11 ) : 1909-1913.
  • 3Rossing K, SchjoedtKJ,JensenBR, et al. Enhanced renoprotective effects of ultrahigh doses of irbcsartan in patients with type 2 diabetes and microalbuminuria. Kidney Int ,2005,68 ( 3 ) : 1190-1198.
  • 4Parring HH, LehnertH, Brochner - MortensenJ, et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N EnjI J Med ,2001,345 (12) :870-878.
  • 5Seger R,Krebs EC.The MAPK signaling cascade.FASEB J,1995,9(9):726-735.
  • 6Li X,Liu W,Wang Q,et al.Emodin suppresses cell proliferation and fibronectin expression via p38MAPK pathway in rat mesangial cells cultured under high glucose.Mol Cell Endocrinol,2009,307(1/2):157-162.
  • 7Sakai N,Wada T,Furuichi K,et al.Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy.Am J Kidney Dis,2005,45(1):54-65.
  • 8Han DC,Hoffman BB,Hong SW,et al.Therapy with antisense TGF-betal oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice.Am J Physiol Renal Physiol,2000,278(4):F628-F634.
  • 9Liu BF,Miyata S,Hirota Y,et al.Methylglyoxal induces apoptosis through activation of p38 mitogen-activated protein kinase in rat mesangial cells.Kidney Iht,2003,63(3):947-957.
  • 10Rane MJ,Song Y,Jin S,et al.Interplay between Akt and p38MAPK pathways in the regulation of renal tubular cell apoptosis associated with diabetic nephropathy.Am J Physiol Renal Physiol,2010,298(1):F49-F61.

引证文献2

二级引证文献10

中国基层医药
2006年 第12期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部